Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$3.07 USD
-0.04 (-1.29%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.06 -0.01 (-0.33%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Puma Biotechnology, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PBYI 3.07 -0.04(-1.29%)
Will PBYI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PBYI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PBYI
Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns
Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?
PBYI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors
Bayer Begins Phase I/II Study on Cell Therapy for Eye Disease
AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer
Other News for PBYI
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results | ...
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | PBYI Stock News
Puma Biotechnology: Updated Timelines And A Resurgence In Sentiment
Puma Biotechnology Updates Bylaws for Compliance
Puma Biotechnology Holds Annual Stockholders Meeting 2025